Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Sci (Lond) ; 133(18): 1993-2004, 2019 09 30.
Article in English | MEDLINE | ID: mdl-31527095

ABSTRACT

Background: Several different mechanisms have been proposed to explain long-term cognitive impairment in sepsis survivors. The role of persisting mitochondrial dysfunction is not known. We thus sought to determine whether stimulation of mitochondrial dynamics improves mitochondrial function and long-term cognitive impairment in an experimental model of sepsis.Methods: Sepsis was induced in adult Wistar rats by cecal ligation and perforation (CLP). Animals received intracerebroventricular injections of either rosiglitazone (biogenesis activator), rilmenidine, rapamycin (autophagy activators), or n-saline (sham control) once a day on days 7-9 after the septic insult. Cognitive impairment was assessed by inhibitory avoidance and object recognition tests. Animals were killed 24 h, 3 and 10 days after sepsis with the hippocampus and prefrontal cortex removed to determine mitochondrial function.Results: Sepsis was associated with both acute (24 h) and late (10 days) brain mitochondrial dysfunction. Markers of mitochondrial biogenesis, autophagy and mitophagy were not up-regulated during these time points. Activation of biogenesis (rosiglitazone) or autophagy (rapamycin and rilmenidine) improved brain ATP levels and ex vivo oxygen consumption and the long-term cognitive impairment observed in sepsis survivors.Conclusion: Long-term impairment of brain function is temporally related to mitochondrial dysfunction. Activators of autophagy and mitochondrial biogenesis could rescue animals from cognitive impairment.


Subject(s)
Cognitive Dysfunction/complications , Cognitive Dysfunction/pathology , Mitochondria/pathology , Sepsis/complications , Sepsis/pathology , Animals , Autophagy/drug effects , Brain/drug effects , Brain/pathology , Disease Models, Animal , Male , Mitochondria/drug effects , Mitochondria/metabolism , Mitochondrial Dynamics/drug effects , Rats, Wistar , Rilmenidine/pharmacology , Rosiglitazone/pharmacology , Sirolimus/pharmacology , Survival Analysis , Up-Regulation/drug effects , Up-Regulation/genetics
2.
Brain Res Bull ; 139: 1-8, 2018 05.
Article in English | MEDLINE | ID: mdl-29374603

ABSTRACT

Evidence has demonstrated iron accumulation in specific brain regions of patients suffering from neurodegenerative disorders, and this metal has been recognized as a contributing factor for neurodegeneration. Using an experimental model of brain iron accumulation, we have shown that iron induces severe memory deficits that are accompanied by oxidative stress, increased apoptotic markers, and decreased synaptophysin in the hippocampus of rats. The present study aims to characterize iron loading effects as well as to determine the molecular targets of cannabidiol (CBD), the main non-psychomimetic compound of Cannabis sativa, on mitochondria. Rats received iron in the neonatal period and CBD for 14 days in adulthood. Iron induced mitochondrial DNA (mtDNA) deletions, decreased epigenetic modulation of mtDNA, mitochondrial ferritin levels, and succinate dehydrogenase activity. CBD rescued mitochondrial ferritin and epigenetic modulation of mtDNA, and restored succinate dehydrogenase activity in iron-treated rats. These findings provide new insights into molecular targets of iron neurotoxicity and give support for the use of CBD as a disease modifying agent in the treatment of neurodegenerative diseases.


Subject(s)
Cannabidiol/therapeutic use , DNA, Mitochondrial/metabolism , Hippocampus/drug effects , Iron Carbonyl Compounds/toxicity , Mitochondria/drug effects , Neurodegenerative Diseases/chemically induced , Neurodegenerative Diseases/drug therapy , 5-Methylcytosine/analogs & derivatives , 5-Methylcytosine/metabolism , Animals , Animals, Newborn , Creatine Kinase/metabolism , DNA Methylation/drug effects , DNA, Mitochondrial/genetics , Disease Models, Animal , Female , Gene Expression Regulation/drug effects , Hippocampus/metabolism , Male , Mitochondria/metabolism , Mitochondrial Proteins/genetics , Mitochondrial Proteins/metabolism , Muscle Proteins/genetics , Muscle Proteins/metabolism , NADH Dehydrogenase/genetics , NADH Dehydrogenase/metabolism , Neurodegenerative Diseases/pathology , Pregnancy , Rats , Rats, Wistar
3.
Mol Neurobiol ; 54(2): 954-963, 2017 03.
Article in English | MEDLINE | ID: mdl-26797515

ABSTRACT

Obesity is a multifactorial disease that comes from an imbalance between food intake and energy expenditure. Moreover, studies have shown a relationship between mitochondrial dysfunction and obesity. In the present study, we investigated the effect of acerola juices (unripe, ripe, and industrial) and its main pharmacologically active components (vitamin C and rutin) on the activity of enzymes of energy metabolism in the brain of mice fed a palatable cafeteria diet. Two groups of male Swiss mice were fed on a standard diet (STA) or a cafeteria diet (CAF) for 13 weeks. Afterwards, the CAF-fed animals were divided into six subgroups, each of which received a different supplement for one further month (water, unripe, ripe or industrial acerola juices, vitamin C, or rutin) by gavage. Our results demonstrated that CAF diet inhibited the activity of citrate synthase in the prefrontal cortex, hippocampus, and hypothalamus. Moreover, CAF diet decreased the complex I activity in the hypothalamus, complex II in the prefrontal cortex, complex II-III in the hypothalamus, and complex IV in the posterior cortex and striatum. The activity of succinate dehydrogenase and creatine kinase was not altered by the CAF diet. However, unripe acerola juice reversed the inhibition of the citrate synthase activity in the prefrontal cortex and hypothalamus. Ripe acerola juice reversed the inhibition of citrate synthase in the hypothalamus. The industrial acerola juice reversed the inhibition of complex I activity in the hypothalamus. The other changes were not reversed by any of the tested substances. In conclusion, we suggest that alterations in energy metabolism caused by obesity can be partially reversed by ripe, unripe, and industrial acerola juice.


Subject(s)
Brain/metabolism , Diet, Western/adverse effects , Energy Metabolism/physiology , Fruit and Vegetable Juices , Malpighiaceae/metabolism , Animals , Antioxidants/administration & dosage , Ascorbic Acid/administration & dosage , Brain/drug effects , Dietary Supplements , Eating/physiology , Energy Metabolism/drug effects , Male , Mice , Obesity/diet therapy , Obesity/etiology , Obesity/metabolism , Plant Extracts/administration & dosage , Plant Extracts/metabolism , Random Allocation
SELECTION OF CITATIONS
SEARCH DETAIL
...